Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severine Vermeire

Showing results (51-60 of 232) with videos related to

Pageof 24
Sort By:
The American Journal of Gastroenterology|March 30, 2004
Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel diseaseNele Esters, Marie Pierik, Kristel van Steen, et al.
Journal of Crohn'S & Colitis|July 13, 2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative ColitisKonstantinos Papamichael, Filip Baert, Sophie Tops, et al.
Gut|January 7, 2011
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relativesMarie Joossens, Geert Huys, Margo Cnockaert, et al.
Inflammatory Bowel Diseases|July 22, 2015
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa StudyAlexander Eser, Jean-Frederic Colombel, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|March 22, 2012
Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitisVicky De Preter, Ingrid Arijs, Karen Windey, et al.
Gut|May 10, 2014
Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBDVicky De Preter, Kathleen Machiels, Marie Joossens, et al.
Nature Reviews. Gastroenterology & Hepatology|March 24, 2020
JAK-STAT pathway targeting for the treatment of inflammatory bowel diseaseAzucena Salas, Cristian Hernandez-Rocha, Marjolijn Duijvestein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2016
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor AntagonistsBrian G Feagan, David T Rubin, Silvio Danese, et al.
Journal of Crohn'S & Colitis|December 4, 2013
Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screeningCeline Debeuckelaere, Paul De Munter, Pascal Van Bleyenbergh, et al.
Plos One|October 2, 2010
Molecular reclassification of Crohn's disease by cluster analysis of genetic variantsIsabelle Cleynen, Jestinah M Mahachie John, Liesbet Henckaerts, et al.
Pageof 24

Showing results (51-60 of 232) with videos related to

Sort By:
Pageof 24
The American Journal of Gastroenterology|March 30, 2004
Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel diseaseNele Esters, Marie Pierik, Kristel van Steen, et al.
Journal of Crohn'S & Colitis|July 13, 2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative ColitisKonstantinos Papamichael, Filip Baert, Sophie Tops, et al.
Gut|January 7, 2011
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relativesMarie Joossens, Geert Huys, Margo Cnockaert, et al.
Inflammatory Bowel Diseases|July 22, 2015
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa StudyAlexander Eser, Jean-Frederic Colombel, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|March 22, 2012
Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitisVicky De Preter, Ingrid Arijs, Karen Windey, et al.
Gut|May 10, 2014
Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBDVicky De Preter, Kathleen Machiels, Marie Joossens, et al.
Nature Reviews. Gastroenterology & Hepatology|March 24, 2020
JAK-STAT pathway targeting for the treatment of inflammatory bowel diseaseAzucena Salas, Cristian Hernandez-Rocha, Marjolijn Duijvestein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2016
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor AntagonistsBrian G Feagan, David T Rubin, Silvio Danese, et al.
Journal of Crohn'S & Colitis|December 4, 2013
Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screeningCeline Debeuckelaere, Paul De Munter, Pascal Van Bleyenbergh, et al.
Plos One|October 2, 2010
Molecular reclassification of Crohn's disease by cluster analysis of genetic variantsIsabelle Cleynen, Jestinah M Mahachie John, Liesbet Henckaerts, et al.
Pageof 24